Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer

Clinical trial NCT03785704 · UNKNOWN

Trial details

NCT number: NCT03785704
Sponsor: Peking Union Medical College
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Cardiac Event Chemotherapeutic Toxicity

Start date: 2019-01-01
Primary completion: 2020-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.